secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2026-04-07T23:59:59+00:00
Accession:  0001493152-26-015365
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics terminates CFO Alexander Arrow, effective April 30, 2026
--------------------------------------------------------------------------------

- CFO Alexander Arrow notified on March 31, 2026 that employment will be terminated.
- Termination effective April 30, 2026; no successor or interim CFO announced.
- Company common stock (PTIX) and warrants (PTIXW) trade on OTC Markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000149315226015365/0001493152-26-015365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000149315226015365/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-015365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer